<PAGE> 1
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): November 3, 2000
AVOCENT CORPORATION
(Exact Name of Registrant as Specified in Charter)
<TABLE>
<S> <C> <C>
DELAWARE 000-30575 91-2032368
(State of Incorporation) (Commission File Number) (I.R.S. Employer
Identification No.)
</TABLE>
4991 CORPORATE DRIVE
HUNTSVILLE, ALABAMA 35805
(Address of Principal Executive Offices/Zip Code)
(205) 430-4000
(Registrant's telephone number, including area code)
<PAGE> 2
Item 2. Acquisition or Disposition of Assets.
As previously reported in the Registrant's Current Report on Form 8-K, dated
November 18, 2000, the Registrant entered into a Plan and Agreement of Merger,
dated as of November 3, 2000, with respect to a merger (the "Merger") by and
among Blue Marlin Acquisition Corporation, a Florida corporation and
wholly-owned subsidiary of the Registrant (the "Subsidiary"), Equinox Systems
Inc., a Florida corporation ("Equinox") and the Registrant, with the Registrant
continuing as the surviving corporation.
The Merger was consummated on January 3, 2001, prior to which the shareholders
of Equinox duly approved the Merger in accordance with the corporate laws of the
State of Florida.
Item 7. Financial Statements, Pro Forma Financial Information and Exhibits.
(a) Financial Statements of Business Acquired. It is impractical to
provide financial statements related to the transactions described herein at
this time. If required, such financial statements will be filed within sixty
(60) days of the date of the filing of this Form 8-K Current Report.
(b) Pro Forma Financial Information. If required, such pro forma
financial statements will be filed within sixty (60) days of the date of the
filing of this Form 8-K Current Report.
(c) Exhibits.
None.
SIGNATURE
Pursuant to the requirements of the Securities and Exchange
Act of 1934, the Registrant has duly caused this report to be signed on its
behalf by the undersigned hereunto duly authorized.
AVOCENT CORPORATION
Dated: January 18, 2001 By: /s/ Doyle C. Weeks
------------------------------------------
Doyle C. Weeks
Executive Vice President
